ArticleMedicine2026

Long-term survival with immune checkpoint inhibitors combined with bevacizumab in advanced clear cell renal cell carcinoma: A case report.

Jing Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.